VAS.DEVAS.DEXETRA
Loading
Cash Flow Under PressureContracting
Percentile Rank50
3Y CAGR-19.1%
5Y CAGR-10.9%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
-19.1%/yr
vs +14.3%/yr prior
5Y CAGR
-10.9%/yr
Recent deceleration
Acceleration
-33.4pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $311.90M | -14.8% |
| 2024 | $366.00M | +79.3% |
| 2023 | $204.10M | -65.3% |
| 2022 | $588.90M | -43.1% |
| 2021 | $1.03B | +86.0% |
| 2020 | $556.10M | +360.0% |
| 2019 | $120.90M | -64.9% |
| 2018 | $344.90M | +319.1% |
| 2017 | $82.30M | +4019.0% |
| 2016 | $-2.10M | - |